Company Type
Limited Corporation
Established
1997
Size
Medium
Employees
100-199 
Revenue
13 MDKK
Gross profit
-
Operating Profit (EBIT)
-467 MDKK
Profit for the Year
499 MDKK
Equity
1,067 MDKK

Score

Score panel requires Premium access

Rank Profit for the Year

Rank in industry
4/911
"Top 10%"
Rank in Denmark
242/297,161
"Top 10%"

Top management Top 3

Board Top 3

Alf Gunnar Martin Nicklasson 1Chairman of board
Kirsten Aarup Drejer 8Vice chairman
Alain Munoz 1Boardmember

Legal owners Top 3

15-19.99%Van Herk Investments B.V.
5-9.99%Sunstone Life Science Ventures Fund I K/S
5-9.99%Wellington Management Group LLP

Rights certificate

Selskabet tegnes af bestyrelsens formand i forening med den administrerende direktør, eller af bestyrelsens formand i forening med et bestyrelsesmedlem, eller af en direktør i forening med 2 bestyrelsesmedlemmer, eller af den administrerende direktør i forening med en direktør eller af den samlede bestyrelse.

Company information based on CVR

NameZealand Pharma A/S
Alternate namesZealand Pharmaceuticals A/S, Connexon A/S, Peptide Probe Technologies A/S, Ppt A/S Show less
CVR20045078
AddressSydmarken 11, 2860 Søborg
IndustryResearch and experimental development on biotechnology [721100]
Webwww.zealandpharma.com
Established01-04-1997 (23 yr)
Company TypeLimited Corporation
Number of employees100-199 (CVR)
Advertising protectionNo
AuditorDeloitte Statsautoriseret Revisionspartnerselskab
Financial statement period01-01 to 31-12
Listed on stock exchangeYes
Nasdaq OMX Copenhagen ZEAL
Company capital36,023,686 DKK
35,865,461 DKK (13-09-2019 - 21-11-2019)
35,806,290 DKK (05-09-2019 - 12-09-2019)
31,831,290 DKK (23-08-2019 - 04-09-2019)
31,814,790 DKK (14-06-2019 - 22-08-2019)
31,725,475 DKK (28-05-2019 - 13-06-2019)
Articles of assoc. last22-11-2019

Purpose

Selskabets formål er at drive forskning, produktion, handel og dermed beslægtet virksomhed, primært indenfor medicinalbranchen.

Financial Statement

 201820172016
Currency/unit000' DKK000' DKK000' DKK
Revenue
13,119
-58%
31,412
+1,697%
1,748
-92%
Gross Profit
-
-
-
-
-
-
Profit for the Year
498,516
-
-171,739
-
-123,274
-
Equity
1,066,912
+94%
549,229
+177%
198,423
-
Total Assets
1,173,621
+91%
615,049
+148%
247,568
-

Map

Loading...
ad

More financial key figures and analyses?

In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!